Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
30.50
0.59 (1.97%)
BSENSE

Dec 05

BSE+NSE Vol: 11.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kabra Drugs Ltd stock-summary
stock-summary
Kabra Drugs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Company Details
270 Shastri Market Indore , Indore Madhya Pradesh : 452007
stock-summary
Tel:
stock-summary
kabradrugs@rediffmail.com
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

None

Highest Public shareholder

Vijay Kumar Reddy Veeramreddy (3.38%)

Individual Investors Holdings

95.0%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
B V Anatha Kumar
Whole Time Director & CFO
0
R Muralidharan
Independent Director
0
Ananthkumar Shilpa
Independent Director
0
Churchil Durai M Jebastine
Independent Director
0
Nidhi Bhaskar
Company Secretary
0
KUNIAMUTHUR NANJAPPAN ANAND
Additional Director
0
Monika Sanwal
Company Sec. & Compli. Officer
0
A Anitha
Additional Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Anaesthetic
1.08
43.13%
Injection/Eye/Ear Drop
0.64
25.68%
Soft Gel Capsule
0.38
15.16%
 
43.13
Anaesthetic
56.87
Anaesthetic
25.68
Injection/Eye/Ear Drop
74.32
Injection/Eye/Ear Drop
15.16
Soft Gel Capsule
84.84
Soft Gel Capsule
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
20 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 72 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.43

stock-summary
Return on Equity

-4.19%

stock-summary
Price to Book

2.74